Bristol-Myers Squibb, Celgene $74B deal under fire from investors
A top investor of Bristol-Myers is opposing the Celgene acquisition.
Trustee: Ocean Resort Casino improving finances, performance
The man overseeing Atlantic City's Ocean Resort Casino until new owners take over says the property is re-stocked with cash and is already starting to turn around its performance.
Was DOJ's case against AT&T-Time Warner merger undermined by Trump?
DOJ loses AT&T-Time Warner merger appeal
Germany's Bayer vows strong defense in Roundup cancer cases
Germany's Bayer AG, which bought Monsanto Co. last year, is underlining its determination to fight cases involving the U.S. company's Roundup weed-killer in the face of more than 11,000 lawsuits so far.
US Appeals Court upholds AT&T deal to buy Time Warner
Wall Street leery of 2020
Elizabeth Warren grills Fed's Powell over BB&T, SunTrust merger
During Powell’s semi-annual testimony on the state of U.S. monetary policy, Warren accused the Fed of rubber-stamping applications for bank mergers and acquisitions.
Sen. Warren questions Fed's Powell over BB&T-SunTrust deal review process
Sen. Warren raises concerns about Fed review of BB&T-SunTrust deal
AT&T-Time Warner deal upheld as DOJ loses appeal
AT&T acquired DirecTV, HBO, CNN and the Warner Bros. film studio as part of the deal.
US appeals court clears AT&T's $81B purchase of Time Warner
A federal appeals court has blessed AT&T's takeover of Time Warner, defeating the Trump administration by affirming that the $81 billion merger won't harm consumers or competition in the booming pay TV market.
T-Mobile-Sprint lean on 5G to sell $26 billion deal and it may backfire
The DOJ is still probing the T-Mobile-Sprint deal over antitrust concerns.
Buffett says Berkshire Hathaway may sell an insurance unit
Billionaire Warren Buffett says his Berkshire Hathaway conglomerate may take the unusual step of selling one of its insurance companies.
Roche buying Spark Therapeutics as firm seeks new patients for landmark drug
The deal comes as big pharma rushes to get in on burgeoning gene therapy treatments.
Barrick goes after Newmont to create $42B gold giant
In acquiring Newmont, the largest U.S. miner, Barrick would create a mining company that could be four times the size of its next closest rival.
GE sells biopharma unit for $21 billion
General Electric is selling its biopharma business to Danaher Corp. for $21.4 billion as the industrial giant continues to shed pieces of itself.
GE to sell BioPharma business to Danaher for $21.4B
GE selling biopharma business to Danaher
GE to sell BioPharma business to Danaher for $21.4B
The deal also includes $21 billion in cash as well as Danaher’s assumption of certain pension liabilities.
Broken-down bus that crashed in China mine was bought online
Safety inspectors say the operators of China's largest silver mine bought a broken down bus online, then overloaded it with miners, leading to brake failure and a crash that left 21 dead and 29 injured.
Roche to buy Spark Therapeutics in $4.3B deal
It is a move by the Swiss drugmaker to expand its presence treating hemophilia.
Buffett's appetite for big deal soured by 'sky-high' prices
Billionaire investor Warren Buffett says he hungers for an "elephant-sized acquisition," but the most tempting targets are too expensive for his tastes.
Merck to buy immunotherapy developer Immune Design for $300M
Immune Design's treatments help activate the immune system to produce or expand specific immune cells to fight cancer and other diseases.